Hims & Hers Health HIMS
NYSE HIMS
$32.28 +1.19 (+3.81%)
At close: Aug 20, 2026 · 3:03 PM UTC

Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026)

Hims & Hers Health (HIMS) posted Amortizatization of Intangibles of $242000.0 for Q1 2026, down 66.34% sequentially from $719000.0 in Q4 2025, and down 65.08% YoY from $693000.0 in Q1 2025.

Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Hims & Hers Health has reported Amortizatization of Intangibles for 7 years, with the latest figure at $242000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 65.08% year-over-year to $242000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 60.19% YoY) and the FY2025 annual result came in at $2.0 million, down 53.34% from the prior year.
  • Amortizatization of Intangibles fell to $242000.0 in Q1 2026 per HIMS's latest filing, from $719000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $1.7 million in Q4 2023 and troughed at -$971000.0 in Q1 2022.
  • A 5-year average of $715823.5 and a median of $840000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 238.33% in 2022, then soared 1333.33% in 2023.
  • Over 5 years, Amortizatization of Intangibles stood at $840000.0 in 2022, then soared by 96.67% to $1.7 million in 2023, then sank by 44.61% to $915000.0 in 2024, then retreated by 21.42% to $719000.0 in 2025, then tumbled by 66.34% to $242000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $242000.0, $719000.0, and $253000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn -
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Hims & Hers Health 7.50 Bn 6.66 Bn 480.80 Mn 96,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 96,000.00
Jun 30, 2026 96,000.00
Mar 31, 2026 242,000.00
Mar 31, 2026 242,000.00
Dec 31, 2025 719,000.00
Dec 31, 2025 719,000.00
Sep 30, 2025 253,000.00
Sep 30, 2025 253,000.00
Jun 30, 2025 367,000.00
Jun 30, 2025 367,000.00
Mar 31, 2025 693,000.00
Mar 31, 2025 693,000.00
Dec 31, 2024 915,000.00
Dec 31, 2024 915,000.00
Sep 30, 2024 1.16 Mn
Sep 30, 2024 1.16 Mn
Jun 30, 2024 1.20 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.08 Mn
Mar 31, 2024 1.08 Mn